Skip to main content
. 2021 Jan;9(1):73. doi: 10.21037/atm-20-5404

Figure 1.

Figure 1

Flowchart of the study. ESCC, oesophageal squamous cell carcinoma; NAIC, neoadjuvant immunochemotherapy; MT, maintain treatment; NAC, neoadjuvant chemotherapy; CRE, clinical response evaluation; QOL, quality of life; NAT, neoadjuvant treatment.